FTSE 100
10.846,70
PKT
+40,29
PKT
+0,37
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.02.26 | National Grid Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.02.26 | Rio Tinto Equal Weight | Barclays Capital | |
| 23.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 23.02.26 | BAT Neutral | Goldman Sachs Group Inc. | |
| 23.02.26 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 20.02.26 | Rio Tinto Halten | DZ BANK | |
| 20.02.26 | Rio Tinto Neutral | UBS AG | |
| 20.02.26 | Rio Tinto Hold | Deutsche Bank AG | |
| 20.02.26 | GSK Underweight | Barclays Capital | |
| 20.02.26 | International Consolidated Airlines Outperform | Bernstein Research | |
| 20.02.26 | National Grid Overweight | JP Morgan Chase & Co. | |
| 20.02.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 19.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.26 | GSK Hold | Deutsche Bank AG | |
| 19.02.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 19.02.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 19.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Rio Tinto Overweight | Barclays Capital | |
| 19.02.26 | BAT Overweight | Barclays Capital | |
| 19.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 19.02.26 | RELX Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Glencore Overweight | Barclays Capital | |
| 18.02.26 | easyJet Underweight | JP Morgan Chase & Co. | |
| 18.02.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.26 | Rolls-Royce Market-Perform | Bernstein Research | |
| 17.02.26 | BAT Buy | Jefferies & Company Inc. | |
| 17.02.26 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.02.26 | Vodafone Group Sell | Goldman Sachs Group Inc. | |
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.02.26 | RELX Outperform | Bernstein Research | |
| 13.02.26 | RELX Buy | UBS AG | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.02.26 | RELX Overweight | Barclays Capital | |
| 12.02.26 | AstraZeneca Halten | DZ BANK | |
| 12.02.26 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | RELX Buy | UBS AG | |
| 12.02.26 | BAT Underperform | RBC Capital Markets | |
| 12.02.26 | BAT Buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.